The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Becton Dickinson Infusion Therapy Systems competitive analysis

Loading summary...

Latest patents of Becton Dickinson Infusion Therapy Systems opposed by its competitors

Explore Becton Dickinson Infusion Therapy Systems's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2325643
Dec 1, 2021Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xv1
EP2322930
Jul 14, 2021Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiv1
EP2325647
Jul 14, 2021Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xx1
EP2325644
Jul 29, 2020Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xii2
EP2325645
Jul 29, 2020Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xiii2
EP2325646
Jan 30, 2019Sequences For Detection And Identification Of Methicillin-Resistant Staphylococcus Aureus (Mrsa) Of Mrej Type Xvii1

Latest PTAB cases involving Becton Dickinson Infusion Therapy Systems

Discover the latest PTAB cases involving Becton Dickinson Infusion Therapy Systems, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Becton Dickinson Infusion Therapy Systems with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BECTON DICKINSON INFUSION THERAPY SYSTEMS - 8 - -
BECKMAN COULTER101113
HERTIN UND PARTNER RECHTS UND PATENTANWALTE PARTG MBB4 - - -